Literature DB >> 15377154

A novel approach for predicting acyl glucuronide reactivity via Schiff base formation: development of rapidly formed peptide adducts for LC/MS/MS measurements.

Jianyao Wang1, Margaret Davis, Fangbiao Li, Farooq Azam, JoAnn Scatina, Rasmy Talaat.   

Abstract

A novel technique to study the reactivity of acyl glucuronide metabolites to protein has been developed and is described herein. Considered here are acyl glucuronide metabolites, which have undergone the rearrangement of the glucuronic acid moiety at physiological temperature and pH. The investigation of the reactivity of these electrophilic metabolites was carried out by measuring the rate of reaction of rearranged AG metabolites in forming the corresponding acyl glucuronide-peptide adduct in the presence of Lys-Phe. This differs from the parallel technique used in forming AG adducts of proteins that have been previously reported. In the study described here, the Schiff base adduct, diclofenac acyl glucuronide-Lys-Phe product, was generated and structurally elucidated by liquid chromatography tandem mass spectrometry (LC/MS/MS) analysis. The product structure was proved to be a Schiff base adduct by chemical derivatization by nucleophilic addition of HCN and chemical reduction with NaCNBH(3), followed by LC/MS/MS analysis. It is proposed here that the degree of reactivity of acyl glucuronides as measured by covalent binding to protein is proportional to the amount of its peptide adduct generated with the peptide technique described. The application of this technique to the assessment of the degree of reactivity of acyl glucuronide metabolites was validated by developing a reactivity rank of seven carboxylic acid-containing drugs. Consistency was achieved between the ranking of reactivity in the peptide technique for these seven compounds and the rankings found in the literature. In addition, a correlation (R(2) = 0.95) was revealed between the formation of a peptide adduct and the rearrangement rate of the primary acyl glucuronide of seven tested compounds. A structure effect on the degree of reactivity has demonstrated the rate order: acetic acid > propionic acid > benzoic acid derivatives. A rational explanation of this order was proposed, based on the inherent electronic and steric properties of each specific aglycone. In addition, adaptation of this technique to automation in order to more rapidly assess the ranking of reactivity of acyl glucuronide covalent binding to proteins by new chemical entities is proposed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15377154     DOI: 10.1021/tx049900+

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  7 in total

Review 1.  Role of biotransformation studies in minimizing metabolism-related liabilities in drug discovery.

Authors:  Yue-Zhong Shu; Benjamin M Johnson; Tian J Yang
Journal:  AAPS J       Date:  2008-03-13       Impact factor: 4.009

2.  Glucuronidation and covalent protein binding of benoxaprofen and flunoxaprofen in sandwich-cultured rat and human hepatocytes.

Authors:  Jennifer Q Dong; Philip C Smith
Journal:  Drug Metab Dispos       Date:  2009-09-22       Impact factor: 3.922

3.  Acylglucuronide in alkaline conditions: migration vs. hydrolysis.

Authors:  Florent Di Meo; Michele Steel; Picard Nicolas; Pierre Marquet; Jean-Luc Duroux; Patrick Trouillas
Journal:  J Mol Model       Date:  2013-02-19       Impact factor: 1.810

4.  Identification of Novel Pathways in Idelalisib Metabolism and Bioactivation.

Authors:  Junjie Zhu; Pengcheng Wang; Amina I Shehu; Jie Lu; Huichang Bi; Xiaochao Ma
Journal:  Chem Res Toxicol       Date:  2018-06-26       Impact factor: 3.739

Review 5.  Analytical tools and approaches for metabolite identification in early drug discovery.

Authors:  Yuan Chen; Mario Monshouwer; William L Fitch
Journal:  Pharm Res       Date:  2006-10-18       Impact factor: 4.580

6.  New Perspectives on Acyl Glucuronide Risk Assessment in Drug Discovery: Investigation of In vitro Stability, In situ Reactivity, and Bioactivation.

Authors:  Mithat Gunduz; Upendra A Argikar; Amanda L Cirello; Jennifer L Dumouchel
Journal:  Drug Metab Lett       Date:  2018

Review 7.  The use of structural alerts to avoid the toxicity of pharmaceuticals.

Authors:  Carmen Limban; Diana C Nuţă; Cornel Chiriţă; Simona Negreș; Andreea L Arsene; Marina Goumenou; Spyros P Karakitsios; Aristidis M Tsatsakis; Dimosthenis A Sarigiannis
Journal:  Toxicol Rep       Date:  2018-08-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.